Crossing the Borders of Nanomedicine

Int J Mol Sci. 2022 Dec 12;23(24):15728. doi: 10.3390/ijms232415728.

Abstract

Nanomedicine, being pressured by the increasing demands for fighting menacing diseases such as cancer, relies pragmatically on consolidated knowledge, namely on therapeutic strategies that are at an advanced stage of experimentation [...].

Publication types

  • Editorial

MeSH terms

  • Humans
  • Nanomedicine*
  • Neoplasms* / drug therapy

Grants and funding

The author work was supported by the grant “Giovani Ricercatori—Third Call” of the Department of Comparative Biomedicine and Food Science, University of Padova (PGR2020/2021/2022).